Shiva Texyarn launches antiviral fabric treated with HeiQ Viroblock NPJ03, a treatment that was proven to deactivate most viruses including coronavirus in the shortest possible time, an innovation from the Swiss textile innovation leader HeiQ Materials AG and co-distributed with Taiwanese Specialty chemical major Jintex Corporation. Shiva Texyarn launches first of its kind antiviral fabrics in the Indian market.
Speaking on the occasion, Carlo Centonze, CEO of HeiQ said, “HeiQ Viroblock is a special combination of our advanced silver and vesicle technology that has been proven effective against the human coronavirus 229E with over 99.99 per cent reduction of virus. It is safe and non-toxic. A patent has been filed. We are pleased to launch this for the first time in India on PPE with Shiva Texyarn.â€Â
Dr Sundararaman KS, Managing Director of Shiva Texyarn, said ” We have been at the forefront of the PPE response in the country, with our Technical Textiles Division being amongst the earliest SITRA Qualified Suppliers of PPE fabric. We have complemented Coverall manufacturing with a range of fabric masks with innovative protective systems and other components of the PPE system. The addition of HeiQ Viroblock to our manufacturing processes gives us another formidable technology in the race to provide high tech, comfortable PPE solutions” The company is currently in the process of getting various international certifications to target the global marketplace for antiviral fabrics.